Patent directory · USPTO A61K / A61P
Patents matching “CRISPR THERAPEUTICS AG”
77 pharma patents match "CRISPR THERAPEUTICS AG" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 77 pharmaceutical patents matching "CRISPR THERAPEUTICS AG" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11649438
Methods and compositions for treating cancer
granted -
US 11622977
Materials and methods for engineering cells and uses thereof in immuno-oncology
granted -
US 11591381
Gene-edited natural killer cells
granted -
US 11578309
Universal donor cells
granted -
US 11564997
Materials and methods for treatment of friedreich ataxia and other related disorders
granted -
US 11566230
Universal donor cells
granted -
US 11559588
Materials and methods for treatment of Spinocerebellar Ataxia Type 1 (SCA1) and other Spinocerebellar Ataxia Type 1 Protein (ATXN1) gene related conditions or disorders
granted -
US 11529427
Gene editing for hemophilia A with improved factor VIII expression
granted -
US 11497773
Genetically engineered t cells with regnase-1 and/or TGFBRII disruption have improved functionality and persistence
granted -
US 11473060
Compositions and methods for differentiating stem cells into NK cells
granted -
US 11471491
Materials and methods for engineering cells and uses thereof in immuno-oncology
granted -
US 11459372
Gene-edited natural killer cells
granted -
US 11433103
Universal donor cells
granted -
US 11434505
Universal donor cells
granted -
US 11407997
Materials and methods for treatment of primary hyperoxaluria type 1 (PH1) and other alanine-glyoxylate aminotransferase (AGXT) gene related conditions or disorders
granted -
US 11389481
Allogeneic cell therapy of B cell malignancies using genetically engineered T cells targeting CD19
granted -
US 11332760
Compositions and methods for genomic editing by insertion of donor polynucleotides
granted -
US 11298378
Materials and methods for engineering cells and uses thereof in immuno-oncology
granted -
US 11254912
Methods and compositions for treating cancer
granted -
US 11207351
Materials and methods for engineering cells and uses thereof in immuno-oncology
granted -
US 11202802
Materials and methods for engineering cells and uses thereof in immuno-oncology
granted -
US 11191783
Materials and methods for engineering cells and uses thereof in immuno-oncology
granted -
US 11174469
Materials and methods for treatment of Amyotrophic Lateral Sclerosis (ALS) and other related disorders
granted -
US 11166985
Materials and methods for engineering cells and uses thereof in immuno-oncology
granted